Study guide
2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's)
ARRT Radiation Therapy Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient Care & Education
1.1 Patient Assessment, History, and Vital Signs 1.2 Psychosocial Support & Coping Mechanisms 1.3 Patient & Family Education on Radiation Therapy 1.4 Radiation Side Effect Management: Skin & Mucosal Reactions 1.5 Radiation Side Effect Management: Systemic & Organ-Specific Side Effects 1.6 Nutritional Support & Management of Dysphagia/Odynophagia 1.7 Medical Emergencies in Radiation Oncology 1.8 Patient Rights, Informed Consent, and Advanced Directives 1.9 Ethical, Legal, and HIPAA Considerations for Radiation Therapists 1.10 Infection Control & Sterile Technique in Radiation Therapy 1.11 Transfer & Positioning Safety for Oncology Patients 1.12 Pharmacology & Contrast Media in Radiation Therapy 1.13 Cancer Epidemiology, Screening & Diagnostic Evaluation
2 Chapter 2: Radiation Physics, Radiobiology & Protection
2.1 Structure of Matter, Electromagnetic & Particulate Radiation 2.2 Radiation Production in Linear Accelerators & X-Ray Tubes 2.3 Photon & Electron Beam Interactions with Matter 2.4 Radiation Measurement Quantities, Units & Dosimeters 2.5 Radiation Protection Principles: ALARA, Time, Distance & Shielding 2.6 NCRP Dose Limits for Occupational & Public Exposure 2.7 Vault Design, Primary & Secondary Protective Barriers 2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's) 2.9 Linear Energy Transfer (LET) & Relative Biological Effectiveness (RBE) 2.10 Acute & Late Radiation Effects on Normal Tissues 2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety 2.12 MRI Magnetic Field Screening for Radiation Therapy Patients
3 Chapter 5: Treatment Sites, Tumors & Classification
5.1 Brain, Spinal Cord Tumors & Metastatic Patterns 5.2 Head & Neck Sites: Anatomy, Lymphatics & Patterns of Spread 5.3 Breast Cancer: Anatomy, Lymphatic Drainage & Radiation Considerations 5.4 Lung & Thoracic Tumors: Anatomy, Spread & Critical Structures 5.5 Abdomen, Pelvis, GI & GU Sites: Anatomy & Metastatic Patterns 5.6 Reproductive System Tumors: Prostate, Cervix & Related Sites 5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies 5.8 Tumor Classification: Histopathology, Grade & Staging Systems
4 Chapter 3: Treatment Planning & Dosimetry
3.1 CT Simulation, Patient Positioning & Target Localization 3.2 Immobilization Devices & Radiopaque Marking Protocols 3.3 ICRU Target Volume Definitions (GTV, CTV, PTV, PRV, OAR) 3.4 Beam Modifiers: Wedges, Compensators, Bolus & MLC Systems 3.5 Depth Dose Characteristics: PDD, TMR, TPR & TAR Relationships 3.6 Monitor Unit (MU) Calculations & Clinical Dosimetry Formulas 3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements 3.8 IMRT, VMAT & Inverse Planning Optimization Concepts 3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques 3.10 Brachytherapy Principles, HDR, LDR & Isotopes 3.11 Dose Volume Histograms (DVH) & QUANTEC Tissue Tolerances
5 Chapter 4: Treatment Delivery, Image Guidance & QA
4.1 Pre-Treatment Chart Check & Plan Verification Protocols 4.2 Daily Patient Positioning, Setup Tolerances & Alignment Verification 4.3 Image-Guided Radiation Therapy (IGRT): Portal Imaging & CBCT Verification 4.4 Linear Accelerator Safety Systems, Interlocks & Gantry Controls 4.5 Special Techniques: TBI, TSI, SGRT & Gated Radiotherapy 4.6 Daily Linac Quality Assurance per AAPM TG-142 Specifications 4.7 Monthly & Annual Linac QA Requirements & Dosimetric Calibration 4.8 Patient-Specific IMRT QA & In-Vivo Dosimetry Verification 4.9 Machine Malfunctions, Override Protocols & Emergency Off Procedures 4.10 Record and Verify (R&V) Systems, EHR Integration & Treatment Documentation
2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's)
Key Takeaways Explain This Topic AI
The Linear-Quadratic Model describes cell survival (S = e^-(αD + βD^2)), where α represents single-track lethal damage and β represents two-track sublethal damage accumulation.
Early-responding tissues and tumors have a high α/β ratio (≈ 10 Gy), making them sensitive to total dose, whereas late-responding tissues have a low α/β ratio (≈ 2-3 Gy), making them sensitive to fraction size.
The 4 R's of Radiotherapy are Repair of sublethal damage, Reoxygenation of hypoxic cells, Repopulation of clonogens, and Reassortment/Redistribution through the cell cycle.
Cells are most radiosensitive during the Mitosis (M) and late G2 phases, and most radioresistant during the late Synthesis (S) phase.
Sublethal damage repair (SLDR) occurs within 2 to 6 hours between fraction doses, requiring adequate inter-fraction spacing to protect late-responding normal tissues.
Last updated: July 2026
Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's)
Quick Reference: Radiobiology examines the biological response of living tissue to ionizing radiation. Nuclear DNA is the principal critical target. Fractionated radiotherapy exploits cell survival curve mathematical dynamics (the Linear-Quadratic model) and the classic 4 R's of radiobiology to maximize tumor kill while sparing normal tissues.
Cellular Target Theory & DNA Damage Mechanics
The primary target responsible for radiation-induced cell death is nuclear deoxyribonucleic acid (DNA) .
Single-Strand vs. Double-Strand DNA Breaks
Single-Strand Breaks (SSB): Radiation severs a single phosphodiester backbone strand. SSBs are readily repaired by cellular DNA ligase enzymes using the intact complementary strand as a template. SSBs rarely lead to cell death.
Double-Strand Breaks (DSB): Radiation severs both complementary backbones within a few base pairs. DSBs are the critical lethal lesions. Mis-repaired or unrepaired DSBs produce lethal chromosomal aberrations during mitosis, including dicentrics , ring chromosomes , and anaphase bridges .
Cell Survival Curve Models & Linear-Quadratic Physics
A cell survival curve plots the logarithm of the surviving fraction of cells ( S S S ) against absorbed radiation dose ( D D D ).
Target Theory Parameters ( D 0 , D q , n D_0, D_q, n D 0 , D q , n )
In single-hit multi-target survival models, three parameters define curve shape:
D 0 D_0 D 0 (Mean Lethal Dose): The dose required to reduce the surviving cell population to 37 % 37\% 37% ( 1 / e 1/e 1/ e ) along the straight exponential portion of the curve. D 0 D_0 D 0 measures intrinsic cellular radiosensitivity (typical mammalian range: 1.0 − 2.0 Gy 1.0-2.0\text{ Gy} 1.0 − 2.0 Gy ).
D q D_q D q (Quasi-Threshold Dose): The width of the initial survival curve shoulder. Represents the cell's capacity to repair sublethal radiation damage.
n n n (Extrapolation Number): The target multiplicity obtained by extrapolating the straight linear slope back to zero dose.
The Linear-Quadratic (LQ) Model
Modern clinical radiobiology utilizes the Linear-Quadratic Model to express cell survival: S = e − ( α D + β D 2 ) S = e^{-(\alpha D + \beta D^2)} S = e − ( α D + β D 2 )
Where:
α \alpha α (Alpha Parameter): Represents single-track lethal damage. A single ionizing particle track causes a lethal double-strand break. Damage is proportional to dose ( D D D ) and is non-repairable.
β \beta β (Beta Parameter): Represents two-track sublethal damage. Two independent particle tracks cause separate single-strand breaks that interact to form a lethal double-strand break. Damage is proportional to dose squared ( D 2 D^2 D 2 ) and is repairable.
The α / β \alpha/\beta α / β Ratio in Tumor & Normal Tissue Responses
The α / β \alpha/\beta α / β ratio is the specific dose at which the linear ( α D \alpha D α D ) and quadratic ( β D 2 \beta D^2 β D 2 ) components of cell kill are exactly equal.
Tissue / Tumor Classification Typical α / β \alpha/\beta α / β Ratio Survival Curve Shape Sensitivity Factor
Early-Responding Tissues & Acute Tumors High α / β ≈ 10 Gy \alpha/\beta \approx 10\text{ Gy} α / β ≈ 10 Gy (Range: 8 − 14 Gy 8-14\text{ Gy} 8 − 14 Gy ) Linear; small shoulder Sensitive primarily to Total Dose (Head & Neck, Lung, Skin, H&N Squamous Cell)
Late-Responding Normal Tissues Low α / β ≈ 2 − 3 Gy \alpha/\beta \approx 2-3\text{ Gy} α / β ≈ 2 − 3 Gy (Range: 1.5 − 4 Gy 1.5-4\text{ Gy} 1.5 − 4 Gy ) Curvilinear; broad shoulder Highly sensitive to Dose per Fraction (Spinal Cord, Brain, Kidney, Bone)
Prostate Adenocarcinoma Ultra-Low α / β ≈ 1.5 Gy \alpha/\beta \approx 1.5\text{ Gy} α / β ≈ 1.5 Gy Curvilinear; very broad shoulder Exceptionally sensitive to large fraction sizes ( Hypofractionation )
The 4 R's of Radiobiology
Fractionated radiation therapy (delivering 1.8 − 2.0 Gy 1.8-2.0\text{ Gy} 1.8 − 2.0 Gy daily fractions over 5 to 7 weeks) relies on the classic 4 R's of Radiobiology (originally described by Withers):
1. Repair of Sublethal Damage (SLDR)
Normal cells repair sublethal quadratic DNA damage ( β D 2 \beta D^2 β D 2 ) within 2 to 6 hours 2\text{ to } 6\text{ hours} 2 to 6 hours after exposure. Fractionation allows normal late-responding tissues to repair sublethal damage between daily fractions, restoring the survival curve shoulder and preventing late organ necrosis.
2. Reoxygenation
Solid tumors contain hypoxic cores ( 2 − 3 × 2-3 \times 2 − 3 × more resistant to low-LET radiation than aerobic cells). As aerobic tumor cells are killed by initial fraction doses, the tumor shrinks and blood supply improves, allowing previously hypoxic cells to reoxygenate and become sensitive to subsequent fractions.
3. Repopulation (Compensatory Proliferation)
Surviving tumor clonogens begin accelerated compensatory proliferation during prolonged treatment courses. In head and neck cancers, accelerated repopulation begins approximately 28 days 28\text{ days} 28 days ( 4 weeks 4\text{ weeks} 4 weeks ) after starting radiotherapy, requiring an extra dose of ∼ 0.6 Gy/day \sim 0.6\text{ Gy/day} ∼ 0.6 Gy/day to offset extended treatment breaks.
4. Reassortment / Redistribution
Cells surviving a radiation fraction progress through the cell cycle and reassort into more sensitive phases (Mitosis M M M and G 2 G_2 G 2 ), increasing cell kill during subsequent fractions.
(Note: A 5th R— Radiosensitivity —refers to intrinsic cellular susceptibility).
Cell Cycle Sensitivity & Radiosensitivity Factors
Mammalian cell radiosensitivity varies dramatically across the cell cycle phases ( G 1 , S , G 2 , M G_1, S, G_2, M G 1 , S , G 2 , M ):
Mitosis ( M M M Phase): Most Radiosensitive . Chromatin is tightly condensed; DNA repair enzymes cannot access breaks.
Late G 2 G_2 G 2 Phase: Highly Radiosensitive .
G 1 G_1 G 1 Phase: Intermediate radiosensitivity.
Late Synthesis ( S S S Phase): Most Radioresistant . Homologous recombination DNA repair enzymes are fully active, and elevated intracellular sulfhydryl compounds scavenge free radicals.